NextCure, Inc. SEC filings NXTC
NextCure, Inc. has 394 filings in SEC EDGAR's recent list, going back to Jan 11, 2016. Its latest annual report, Form 10-K, was filed on Mar 5, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 425 | Filing | Sep 25, 2026 | — |
| 425 | Filing | Aug 10, 2026 | — |
| 425 | Filing | Aug 4, 2026 | — |
| 425 | Filing | Jul 16, 2026 | — |
| 425 | Filing | Jul 14, 2026 | — |
| EFFECT | Filing | Dec 11, 2025 | — |
| D | Filing | Dec 10, 2025 | — |
| CORRESP | Letter to the SEC | Dec 9, 2025 | — |
| EFFECT | Filing | Jul 29, 2025 | — |
| CORRESP | Letter to the SEC | Jul 28, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 24, 2025 | — |
| EFFECT | Filing | Aug 11, 2023 | — |
| CORRESP | Letter to the SEC | Aug 9, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 8, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 29, 2021 | — |
| CORRESP | Letter to the SEC | Apr 26, 2021 | — |
| UPLOAD | Letter from the SEC | Apr 15, 2021 | — |
| EFFECT | Filing | Mar 12, 2021 | — |
| POSASR | Filing | Mar 4, 2021 | — |
| SEC STAFF LETTER | Filing | Feb 19, 2020 | — |
| SEC STAFF LETTER | Filing | Feb 10, 2020 | — |
| EFFECT | Filing | Nov 14, 2019 | — |
| CORRESP | Letter to the SEC | Nov 12, 2019 | — |
| CORRESP | Letter to the SEC | Nov 12, 2019 | — |
| UPLOAD | Letter from the SEC | Nov 6, 2019 | — |
| DRS | Filing | Oct 30, 2019 | — |
| EFFECT | Filing | May 8, 2019 | — |
| CERT | Filing | May 8, 2019 | — |
| 8-A12B | Filing | May 8, 2019 | — |
| SEC STAFF LETTER | Filing | May 7, 2019 | — |
| CORRESP | Letter to the SEC | May 6, 2019 | — |
| SEC STAFF LETTER | Filing | Apr 29, 2019 | — |
| CORRESP | Letter to the SEC | Apr 17, 2019 | — |
| DRSLTR | Filing | Apr 1, 2019 | — |
| DRS/A | Filing | Apr 1, 2019 | — |
| UPLOAD | Letter from the SEC | Mar 13, 2019 | — |
| DRSLTR | Filing | Mar 5, 2019 | — |
| DRS/A | Filing | Mar 5, 2019 | — |
| UPLOAD | Letter from the SEC | Feb 25, 2019 | — |
| DRSLTR | Filing | Jan 30, 2019 | — |
| DRS | Filing | Jan 30, 2019 | — |
| D | Filing | Nov 19, 2018 | — |
| D | Filing | Jan 11, 2016 | — |
Showing 43 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NXTC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Baltimore, MD
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1661059
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.